Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS

被引:1
|
作者
Jin, Xiu [1 ]
Liu, Feifei [1 ]
Zhang, Ya [2 ]
Ma, Yingying [3 ]
Yang, Linqing [3 ]
Wang, Yunfei [3 ]
Liu, Ying [3 ]
机构
[1] Jining Med Univ, Affiliated Hosp, Dept Pathol, Jining, Shandong, Peoples R China
[2] Jining Med Univ, Affiliated Hosp, Dept Obstet, Jining, Shandong, Peoples R China
[3] Jining Med Univ, Dept Gynecol, Affiliated Hosp, Jining, Shandong, Peoples R China
关键词
Cervical cancer; ASCUS; HPV E6/E7 mRNA; Menopause; Colposcope; CERVICAL-CANCER; PREVENTION; WOMEN; PERFORMANCE; POPULATION; LESIONS;
D O I
10.1186/s12905-023-02599-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To investigate the infection status of high-risk human papillomavirus (HR-HPV) E6/E7 mRNA in patients with a cytological diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) and to analyze the pathogenic rate of different high-risk HPV subtypes combined with biopsy pathological results to provide a more accurate basis for managing ASCUS patients.Methods A total of 1387 patients with ASCUS and HPV E6/E7 mRNA positivity who were referred for colposcopy were retrospectively analyzed. They were divided into HPV16+, 18/45 + and other HR-HPV + groups premenopausal and postmenopausal groups. The pathological results of the biopsy were divided into the LSIL- group (including normal and low-grade squamous intraepithelial lesions) and the HSIL + group (including high-grade squamous intraepithelial lesions and higher lesions). SPSS was used for the analysis.Results The age group 31-40 years had the highest level of HPV16+, and HPV18/45 + was the highest in the 41-50 years group. The detection rates of HSIL + in the HPV16+, HPV18/45+, HPV 16/18/45 + and Other HR-HPV + groups were 48.4%, 18.8%, 43.9% and 15.0%, respectively. The infection rates of HPV16/18/45 in postmenopausal and premenopausal women were 42.4% and 34.3%, respectively. In the HPV18/45 group, the incidence of HSIL + was 30.0% in postmenopausal women and 15.0% in premenopausal women (P < 0.01). In the HPV 16 + and Other HR-HPV + groups, the incidence of HSIL + in postmenopausal patients was not significantly different from that in premenopausal patients. The incidence of cervical cancer in postmenopausal patients is significantly higher than that in premenopausal patients.Conclusions Colposcopy referral or further biopsy is recommended for all ASCUS patients with HPV16/18/45E6/E7 mRNA positivity and postmenopausal patients with HR-HPVE6/E7 mRNA positivity. For premenopausal ASCUS patients with other HR-HPV E6/E7 mRNA positivity, colposcopy should be performed if possible, depending on the specific situation, to achieve early detection and diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Role of E6/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system
    Zappacosta, Roberta
    Gatta, Daniela Maria Pia
    Marinucci, Pierluigi
    Capanna, Serena
    Lattanzio, Giuseppe
    Caraceni, Donatella
    Rosini, Sandra
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (01) : 137 - 150
  • [32] HPV E6/E7 mRNA transcripts as predictors of high-grade epithelial cervix dysplasia
    J Möckel
    A Clad
    A-S Endres
    V Schneider
    Diagnostic Pathology, 2 (Suppl 1)
  • [33] Association between vaginal microflora, high-risk hpv infection and hpv e6/e7 expression in high grade cervical intraepithelial neoplasia
    Plisko, O.
    Zodzika, J.
    Jermakova, I.
    Rezeberga, D.
    Kroica, J.
    Liepniece-Karele, I.
    Araja, D.
    Kunicina, D.
    Prusakevica, A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E31 - E31
  • [34] RETRACTED: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL (Retracted Article)
    Cao, Limei
    He, Ping
    Yang, Jun
    Long, Xin
    Chen, Yanqiu
    Yan, Li
    Zhou, Deping
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [35] The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening
    Fan, Yibing
    Shen, Zongji
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (05) : 767 - 775
  • [36] Analysis of HPV E6/E7 mRNA expression in asymptomatic subjects: A pilot study
    Mazzoli, S.
    Cai, T.
    Meacci, F.
    Addonisio, P.
    Malossini, G.
    Selli, C.
    Bartoletti, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E304 - E304
  • [37] Evaluation of E6 and E7 mRNA expression in HPV DNA positive breast cancer
    Frega, A.
    Lorenzon, L.
    Bononi, M.
    De Cesare, A.
    Ciardi, A.
    Lombardi, D.
    Assorgi, C.
    Gentile, M.
    Moscarini, M.
    Torrisi, M. R.
    French, D.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (02) : 164 - 167
  • [38] 120例高危HPV E6/E7 mRNA检测结果分析
    张凤芹
    张清泉
    侯素平
    冀雪霞
    张宪军
    杜素果
    国际检验医学杂志, 2014, 35 (17) : 2396 - 2397
  • [39] DETECTION OF HPV E6/E7 MRNA USING NUCLISENS EASYQ HPV™ IN ABNORMAL CYTOLOGY SPECIMENS
    Guvenal, T.
    Birge, O.
    Ulkumen, B. Artunc
    Akcali, S.
    Sanlidag, T.
    Koltan, S. O.
    Koyuncu, F. M.
    Kandiloglu, A. R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [40] High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
    Zheng, Yunji
    Li, Xue
    Jiao, Yisheng
    Wu, Chengjun
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12